Results 121 to 130 of about 15,183 (185)

Different Risk Factors of Rod Fracture between L5-S1 and ≥ L4-5 Levels in Adult Spinal Deformity Surgery. [PDF]

Clin Orthop Surg
Kang DH, Park JS, Park SJ.
europepmc   +1 more source

Assessment of the efficacy and safety of anti-sclerostin antibody therapy for osteoporosis in postmenopausal women: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Endocrinol (Lausanne)
Chen L, Wang Q, Gu M.
europepmc   +1 more source

Malignant transformation in patients with monoclonal gammopathy of undetermined significance treated with teriparatide for osteoporosis: a bicenter retrospective study and analysis of the French national pharmacovigilance database. [PDF]

Arch Osteoporos
Cassez R, Cortet B, Bouvard B, Theis D, Potey C, Manier S, Paccou J, Philippoteaux C.   +7 more
europepmc   +1 more source

Conservative treatments for non-surgically managed osteoporotic vertebral compression fractures: a network meta-analysis of long-term pain and quality of life. [PDF]

Osteoporos Int
Chao WC, Chen YH, Shih JC, Cheng B, Hu MH.   +4 more
europepmc   +1 more source

Pre-Operative Bone Health in Elective Spine Surgery, From Risk Assessment to Optimization Strategies: A Narrative Review. [PDF]

Global Spine J
Ng MK, Hitchner M, Dalton J, Lee Y, Green WA, Baek G, Mathew J, Eichbaum YK, Hilibrand AS, Vaccaro AR, Schroeder GD, Kepler CK.   +11 more
europepmc   +1 more source

First Reported Use of Recombinant Parathyroid Hormone in Kenny-Caffey Syndrome Type 2: A Case Report and Literature Review. [PDF]

Diseases
Djordjevic Milosevic M, Skakic A, Andjelkovic M, Delgado-Vega AM, Thonberg H, Klaassen K, Komazec J, Kecman B, Jocic N, Björck E, Lindstrand A, Stojiljkovic M.   +11 more
europepmc   +1 more source

Atypical Fracture From Bisphosphonate Use in Hypophosphatasia With Improved Bone Response to Teriparatide Therapy. [PDF]

JCEM Case Rep
Mora Garzon E, Betancourt Zuluaga D, Salazar Ospina JD, López Velásquez S.   +3 more
europepmc   +1 more source

Comparative efficacy and safety of teriparatide versus bisphosphonates in osteoporosis: a meta-analysis. [PDF]

Front Surg
Jin H, Dong Y, Huang C, Wang D, He Z, Shen L, Ma C, Wang Z, Shi S, Shuai B.   +9 more
europepmc   +1 more source

Bone density and remodeling after discontinuation of sequential therapy for premenopausal idiopathic osteoporosis. [PDF]

Osteoporos Int
Cohen A, Kamanda-Kosseh M, Rawal R, Agarwal S, Barry J, Shiau S, Colon I, Bucovsky M, Lappe JM, Shane E.   +9 more
europepmc   +1 more source

The Efficacy and Safety of Abaloparatide in Osteoporosis: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Bonifacio M, Ruggiero M, Lucchetti L, Musorrofiti MG, La Cava G, Chiappetta A, Fiorino E, Lo Gullo A, Conforti A.   +8 more
europepmc   +1 more source